Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. COVID-19
  4. Alterations in smell or taste in individuals infected with SARS-CoV-2 during periods of Omicron variant dominance

Alterations in smell or taste in individuals infected with SARS-CoV-2 during periods of Omicron variant dominance

International Journal of Infectious Diseases, 2023 · DOI: https://doi.org/10.1016/j.ijid.2023.01.017 · Published: January 10, 2023

COVID-19ImmunologyNeurology

Simple Explanation

This study investigated the prevalence and severity of smell and taste alterations (STAs) in patients infected with the Omicron variant of SARS-CoV-2. It also examined the correlation between these alterations and initial symptoms, as well as the protective role of vaccination. The study found that the prevalence of STAs remained relatively constant during the Omicron dominance. However, the severity of STAs was reduced, and vaccination showed a protective effect against developing these alterations. The research suggests that the presence of STAs could be an important indicator of the virus invading the nervous system. Patients with initial symptoms like headache and muscle pain were more likely to develop STAs.

Study Duration
May 17 and June 16, 2022
Participants
688 participants at T1 and 385 at T2, infected with SARS-CoV-2 Omicron
Evidence Level
Not specified

Key Findings

  • 1
    The prevalence of smell and taste alterations did not significantly decrease during the Omicron dominance compared to earlier phases of the pandemic.
  • 2
    The severity of smell and taste alterations was reduced during the Omicron dominance.
  • 3
    Vaccination, particularly three doses, demonstrated a protective effect against developing smell and taste alterations.

Research Summary

This study comprehensively analyzed the prevalence, severity, and characteristics of smell and taste alterations (STAs) in patients infected with the SARS-CoV-2 Omicron variant. The findings suggest that while the prevalence of STAs remained consistent, the severity decreased during the Omicron period, and vaccination showed a protective effect. The study also indicates that STAs might be a significant indicator of viral invasion of the nervous system, with headache and muscle pain as initial symptoms correlating with a higher likelihood of developing STAs.

Practical Implications

Public Health

Continued public health attention is required due to the high contagiousness of the Omicron variant, despite its reported lower severity, because the large patient base exposes more people to complications like olfactory and gustatory dysfunction.

Diagnostic Approaches

Consideration of smell and taste alterations as part of the screening and diagnostic approaches for COVID-19 could improve early detection rates and curtail the spread of the virus.

Neurological Impact

Further exploration is needed to understand the possibility of early intervention to reduce the prevalence and protect neurological function, given that altered smell or taste is likely an important indication of viral invasion into the nervous system.

Study Limitations

  • 1
    The study was conducted on patients with mild illness in mobile cabin hospitals, limiting the generalizability to severe patients.
  • 2
    The assessment method was essentially subjective self-reporting, which may be biased.
  • 3
    The study was based on a cross-sectional survey, which was geographically limited and had no data on the follow-up process of the disease.

Your Feedback

Was this summary helpful?

Back to COVID-19